Our study suggests that CH-hMSCs and PL-hMSCs inhibited breast cancer cell proliferation by negatively regulating CyclinD1 expression and upregulating the expression of the P16 and P21 genes. This evidence concerns the gene CCND1 and breast carcinoma.